Zobrazeno 1 - 10
of 16
pro vyhledávání: '"M P Leese"'
Autor:
Y T Ho, A. Purohit, Helena J. Tutill, Michael J. Reed, Simon P. Newman, Paul A. Foster, M P Leese, Joanna M. Day, Barry V. L. Potter
Publikováno v:
British Journal of Cancer
The anti-proliferative and anti-angiogenic properties of the endogenous oestrogen metabolite, 2-methoxyoestradiol (2-MeOE2), are enhanced in a series of sulphamoylated derivatives of 2-MeOE2. To investigate possible mechanisms of resistance to these
Autor:
A. Purohit, Sarah Louise Claire Tagg, Michael J. Reed, M P Leese, Simon P. Newman, Barry V. L. Potter, Paul A. Foster
Publikováno v:
British Journal of Cancer
Drug combination therapy is a key strategy to improve treatment efficacy and survival of cancer patients. In this study the effects of combining 2-methoxyoestradiol-3,17-O,O-bis-sulphamate (STX140), a microtubule disruptor, with 2-deoxy-D-glucose (2D
Autor:
Barry V. L. Potter, Michael F.C. Parsons, A. Purohit, Paul A. Foster, Surinder K. Chander, Michael J. Reed, M P Leese, Simon P. Newman, R Jhalli
Publikováno v:
British Journal of Cancer
The steroidal-based drug 2-ethyloestradiol-3,17-O,O-bis-sulphamate (STX243) has been developed as a potent antiangiogenic and antitumour compound. The objective of this study was to ascertain whether STX243 is more active in vivo than the clinically
Autor:
Paul A. Foster, Simon P. Newman, Joanna M. Day, Bindumalini Raobaikady, Michael J. Reed, Y T Ho, Barry V. L. Potter, M P Leese, Philip G. Kasprzyk, A. Purohit
Publikováno v:
British Journal of Cancer
Therapies for hormone-independent prostate and breast cancer are limited, with the effectiveness of the taxanes compromised by toxicity, lack of oral bioavailability and drug resistance. This study aims to identify and characterise new microtubule di
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 94:167-172
Synthesis of oestrone from androstenedione within tumours, by the aromatase enzyme complex, is an important source of oestrogen that is available to support the growth of hormone-dependent breast tumours. In view of the central role that the aromatas
Autor:
Graham Packham, M P Leese, A. Purohit, Michael J. Reed, Amalia Mouzakiti, Barry V. L. Potter, L. Wood
Publikováno v:
Apoptosis. 9:323-332
2-Methoxyoestradiol (2-MeOE2) is an endogenous oestrogen metabolite which inhibits tubulin polymerisation and has anti-tumour and anti-angiogenic activity. 2-MeOE2 induces apoptosis in a wide range of cancer cell types and has recently been demonstra
Autor:
Atul Purohit, Christopher R. Ireson, Surinder K. Chander, Simon P. Newman, B V L Potter, D. C. Parish, S Perera, A C Smith, Michael J. Reed, M P Leese
Publikováno v:
British Journal of Cancer
2-Methoxyoestradiol (2-MeOE2) is an endogenous oestrogen metabolite that inhibits the proliferation of cancer cells in vitro, and it is also antiangiogenic. In vivo 2-MeOE2, when administered at relatively high doses, inhibits the growth of tumours d
Autor:
James J. Robinson, Simon P. Newman, L W L Woo, Y T Ho, Nigel Vicker, Dharshini Ganeshapillai, A. Purohit, Michael J. Reed, Barry V. L. Potter, M P Leese
Publikováno v:
Biochemical and Biophysical Research Communications. 305:909-914
Carbonic anhydrases (CAs) are expressed by many solid tumours where they may act to confer a growth advantage on malignant tissues. In this study we have examined the ability of a series of steroidal and non-steroidal sulphamates (originally develope
Autor:
Klaus Hellgardt, Jonathan M. J. Williams, Amin R. Mirza, M P Leese, Michael S. Anson, David F. Thompson, and Louise Tonks
Publikováno v:
Organic Process Research & Development. 2:325-331
Heck reactions using sulphonated triphenylphosphine palladium complexes have been carried out using a supported liquid-phase catalysis system in a batch reactor. The catalyst complex is held in solution in a polar, hydrophilic film supported upon por
Autor:
Simon P. Newman, Surinder K. Chander, Barry V. L. Potter, A. Purohit, Toshiaki Utsumi, M P Leese, Michael J. Reed, K. Gaukroger
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 94(1-3)
2-Methoxyoestrogen sulphamates are a new class of compounds, which inhibit breast cancer cell proliferation and are also potent inhibitors of steroid sulphatase (STS) activity. In the present study, we have used two cell proliferation assays (MTS and